Net Cash Provided by (Used in) Operating Activities |
-36.5K |
USD |
-12.8% |
Dec 31, 2023 |
Q4 2023 |
Net Cash Provided by (Used in) Financing Activities |
36.5K |
USD |
+12.8% |
Dec 31, 2023 |
Q4 2023 |
Common Stock, Shares Authorized |
15B |
shares |
0% |
Dec 31, 2023 |
Q4 2023 |
Common Stock, Shares, Issued |
15B |
shares |
0% |
Dec 31, 2023 |
Q4 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Dec 31, 2023 |
Q4 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
0 |
USD |
|
Mar 31, 2022 |
Q1 2022 |
Deferred Tax Assets, Valuation Allowance |
24K |
USD |
-3.24% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
-100% |
Mar 31, 2023 |
Q1 2023 |
Preferred Stock, Shares Authorized |
25M |
shares |
|
Dec 31, 2023 |
Q4 2023 |
Additional Paid in Capital |
30.6M |
USD |
0% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
-100% |
Mar 31, 2023 |
Q1 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Dec 31, 2023 |
Q4 2023 |